Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis

Systemic sclerosis (SSc) is a rare connective tissue disorder characterized by immune dysregulation evoking the pathophysiological triad of inflammation, fibrosis and vasculopathy. In SSc, several alterations in the B-cell compartment have been described, leading to polyclonal B-cell hyperreactivity...

Descripción completa

Detalles Bibliográficos
Autores principales: Graßhoff, Hanna, Fourlakis, Konstantinos, Comdühr, Sara, Riemekasten, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496142/
https://www.ncbi.nlm.nih.gov/pubmed/36140251
http://dx.doi.org/10.3390/biomedicines10092150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496142/
https://www.ncbi.nlm.nih.gov/pubmed/36140251
http://dx.doi.org/10.3390/biomedicines10092150

Ejemplares similares